For decades, the war on cancer has focused on destroying cancer cells directly - with chemotherapy, radiation, and targeted drugs. But what if the future of cancer treatment is not about attacking cancer ourselves...but teaching our own immune system to do it for us?
Today we're exploring a new generation of immunotherapies designed to turn the body's own defenses into a precision weapon against cancer.
Over the past decade, immunotherapies such as checkpoint inhibitors and CAR-T cell therapies have transformed the treatment landscape for many cancers. But major challenges remain - including limited response rates, treatment resistance, toxicity, and the enormous complexity and cost of manufacturing many next-generation therapies.
Our guest today believes the next breakthrough may come from a new generation of personalized immunotherapies designed to activate a patient’s own immune system against their cancer - while also being manufactured as an accessible, off-the-shelf treatment.
Joining us is Dr. William Williams, MD - President and CEO of BriaCell Therapeutics ( https://briacell.com/ ).
Dr. Williams brings more than 35 years of experience spanning academia and the biopharmaceutical industry. He has helped advance numerous medicines from discovery through clinical development, including work contributing to therapies such as Jakafi and Olumiant during his time at Incyte, and multiple oncology programs during his career at GlaxoSmithKline.
Before entering industry leadership, Dr. Williams was a researcher at the University of Pennsylvania focused on molecular immunology, receptor biology, and early DNA vaccine approaches.
Today we’ll discuss the evolution of cancer immunotherapy, BriaCell’s Bria-IMT platform, the challenges of treating advanced breast cancer, and whether the future of oncology lies in creating therapies that can truly mobilize each patient’s own immune system.
Podden och tillhörande omslagsbild på den här sidan tillhör
Ira Pastor. Innehållet i podden är skapat av Ira Pastor och inte av,
eller tillsammans med, Poddtoppen.
